Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantRadiation DosageRadiation, IonizingRadiation InjuriesDose-Response Relationship, RadiationCombined Modality TherapyRadiation ToleranceRadiationAntineoplastic AgentsRadiation ProtectionCisplatinRadiation MonitoringTreatment OutcomeDoxorubicinCyclophosphamideNeoadjuvant TherapyRadiotherapyDisease-Free SurvivalBreast NeoplasmsNeoplasm StagingRadiation OncologySurvival AnalysisEtoposideSurvival RateRadiotherapy DosagePrognosisRadiation PneumonitisDrug Administration ScheduleCosmic RadiationRadiation Injuries, ExperimentalNeoplasm Recurrence, LocalLung NeoplasmsMethotrexateNeoplasmsCarboplatinNeoplasms, Radiation-InducedPaclitaxelRadiotherapy, AdjuvantGamma RaysVinblastineInduction ChemotherapyBackground RadiationTaxoidsBleomycinTime FactorsDrug Resistance, NeoplasmFollow-Up StudiesRadiometryIfosfamideDeoxycytidineAntimetabolites, AntineoplasticBrain NeoplasmsOrganoplatinum CompoundsRadiation-Sensitizing AgentsAntineoplastic Agents, AlkylatingCarcinoma, Non-Small-Cell LungAdenocarcinomaUltraviolet RaysRadiation EffectsSalvage TherapyHodgkin DiseaseRadiation-Protective AgentsNeoplasm MetastasisAnthracyclinesDose FractionationCytarabineLymphoma, Non-HodgkinRadiotherapy, ConformalChemotherapy, Cancer, Regional PerfusionOvarian NeoplasmsDacarbazineTesticular NeoplasmsCell Line, TumorAntineoplastic Agents, PhytogenicCarcinoma, Squamous CellVomitingProspective StudiesNeutropeniaTransplantation, AutologousHead and Neck NeoplasmsChemoradiotherapyNauseaClinical Trials as TopicCranial IrradiationKaplan-Meier EstimateColorectal NeoplasmsRadiotherapy, Intensity-ModulatedAcute Radiation SyndromeBone NeoplasmsLomustineAntibiotics, AntineoplasticTomography, X-Ray ComputedCarmustineBrachytherapyDNA DamageNeoplasms, Germ Cell and EmbryonalCobalt RadioisotopesDose-Response Relationship, DrugCamptothecin